ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010